Top compounds associated with response to EBLN1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.072 0.04
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.04
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.05
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA MI-2 CTRPv2 pan-cancer AAC -0.1 0.05
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.069 0.05
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC -0.08 0.05
mRNA simvastatin CTRPv2 pan-cancer AAC -0.075 0.05
Download CSV